Aprogen

007460 · KOSPI · Health Care · SMALL CAP

Decision to acquire shares/equity in another company (subsidiary)

M&A(Decision to acquire shares/equity in another company (subsidiary))· FILED 2026-07-02· RCEPT 20260702800285

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-09-18) →

About this filing

A decision to buy or sell a business, a major asset or shares in another company, with the counterparty and price.

Why companies file it: Large acquisitions and disposals relative to the company's size are mandatory disclosures.

A full English translation of this filing is not available yet. The original (in Korean) is linked below.

Filed2026-07-02, Decision to acquire shares/equity in another company (subsidiary)
SourceDART rcept 20260702800285 → open original filing

Versions of this filing

  1. 2026-07-02Original (this page)
  2. 2026-09-18Amendment 1

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-02 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).